01 January 1970 15 4K Report

Dear Colleagues,

The occurrence of a new, extremely pathogenic betacoronavirus, SARS-CoV-2 (2019-nCoV), is responsible for the CoVid-19 pandemic health emergency. Accordingly, SARS-CoV-2 represents a serious global health warning characterized by high mortality, a high contagion rate, and a lack of clinically approved drugs and vaccines. In order to find safe and effective therapeutic options to treat this infectious disease, computer science could play an extremely relevant role to better understand the virus pathogenic mechanism as well as to propose novel therapeutic strategies. Accordingly, due to progress in computer science, in silico methodologies in medicinal chemistry, pharmacology, biology, genetics, and virology cover relevant tasks in modern research in these fields. Furthermore, due to the current global health warning, such computational techniques could speed up research in order to provide innovative and targeted approaches to fight the coronavirus emergency. In light of this, this Special Issue will highlight progress in terms of drug discovery, virus biology, and epidemiology to provide researchers with the most innovative computer-driven methodologies for fighting SARS-CoV-2.

For this Special Issue of Computation, we invite researchers in the fields of computational drug discovery (including drug repurposing approaches), computational biology/genetics, virology, bioinformatics, and epidemiology to submit original research, short communications, and review articles related to the use of computation to fight SARS-CoV-2.

Dr. Simone Brogi Prof. Vincenzo Calderone Guest Editors

https://www.mdpi.com/journal/computation/special_issues/computation_CoVid_19

More Simone Brogi's questions See All
Similar questions and discussions